ENTRADA THERAPEUTICS INC (TRDA) Stock Cash Flow
NASDAQ:TRDA - Nasdaq - US29384C1080 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 24.78M | 65.63M | -6.68M | -94.62M | -51.16M | |||
| Depreciation Amortization | 3.79M | 3.77M | 2.84M | 1.90M | 1.12M | |||
| Income Taxes - Deferred | N/A | N/A | 139.98M | N/A | N/A | |||
| Change In Working Capital | -93.06M | -118.85M | 136.31M | -11.11M | -3.42M | |||
| Taxes Paid | N/A | 4.62M | 14.72M | N/A | N/A | |||
| Other non cash items | 9.95M | 7.90M | 7.33M | 10.05M | 2.60M | |||
| OPERATING CASH FLOW | -54.55M | -41.56M | 139.80M | -93.79M | -50.86M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.46M | -3.16M | -5.61M | -2.89M | -4.58M | |||
| Other Investing Activity | -45.70M | -24.64M | -132.78M | -145.76M | N/A | |||
| INVESTING CASH FLOW | -49.16M | -27.80M | -138.40M | -148.65M | -4.58M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 103.11M | 102.96M | 21.04M | 480.00K | 307.46M | |||
| FINANCING CASH FLOW | 103.11M | 102.96M | 21.04M | 480.00K | 307.46M | |||
| CHANGE IN CASH | -599.00K | 33.61M | 22.45M | -241.96M | 252.02M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -54.55M | -41.56M | 139.80M | -93.79M | -50.86M | |||
| Capital Expenditure | -3.46M | -3.16M | -5.61M | -2.89M | -4.58M | |||
| FREE CASH FLOW | -58.01M | -44.72M | 134.19M | -96.68M | -55.44M | |||
All data in USD